{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:27:28Z","timestamp":1760059648134,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Medullary thyroid carcinoma is a rare neuroendocrine malignancy, with sporadic and hereditary forms accounting for 75% and 25% of cases, respectively. This study compares the clinicopathological features of sporadic medullary thyroid carcinoma (sMTC) and hereditary medullary thyroid carcinoma (hMTC) using real-world data to provide risk factors that aid in the early detection of the disease. Materials and Methods: The retrospective study comprised 77 patients with confirmed MTC treated at a tertiary referral center between January 2019 and December 2024. Patients were classified as hMTC (n = 11) or sMTC (n = 66) based on RET proto-oncogene (RET) genetic testing, whereas harboring a germline RET mutation indicated hMTC. Demographic, clinical, laboratory, radiological, histopathological, and genetic data were collected. Results: hMTC patients were significantly younger at diagnosis, with a comparable gender distribution (p = 0.738), and more often had a previous case of MTC within the family history. Pheochromocytoma occurred exclusively in hMTC. Multicentric tumors were more frequent in hMTC, and non-diagnostic Bethesda I cytology was higher in hMTC. Conclusions: While confirming established differences, this study provides detailed pre-operative diagnostic parameters and surgical approaches that can guide clinical decision-making in resource-limited settings where genetic testing may not be immediately available.<\/jats:p>","DOI":"10.3390\/medicina61071164","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T03:54:28Z","timestamp":1751255668000},"page":"1164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study on the Multidimensional Features of Hereditary and Sporadic Medullary Thyroid Carcinoma Patients: A Single-Center Retrospective Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8905-3955","authenticated-orcid":false,"given":"Muzaffer Serdar","family":"Deniz","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism Diseases, Ankara Bilkent City Hospital, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narin","family":"Nasiroglu Imga","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Diseases, Ankara Bilkent City Hospital, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-7706","authenticated-orcid":false,"given":"Belma Ozlem","family":"Tural Balsak","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Diseases, Ankara Bilkent City Hospital, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asiye","family":"Safak Bulut","sequence":"additional","affiliation":[{"name":"Deparment of Pathology, Ankara Bilkent City Hospital, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furkan","family":"Savas","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Breast and Endocrine Surgery Clinic, Ankara Bilkent City Hospital, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Busranur","family":"Cavdarli","sequence":"additional","affiliation":[{"name":"Deparment of Medical Genetic, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cevdet","family":"Aydin","sequence":"additional","affiliation":[{"name":"Deparment of Endocrinology and Metabolic Diseases, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oya","family":"Topaloglu","sequence":"additional","affiliation":[{"name":"Deparment of Endocrinology and Metabolic Diseases, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Ersoy","sequence":"additional","affiliation":[{"name":"Deparment of Endocrinology and Metabolic Diseases, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"Cakir","sequence":"additional","affiliation":[{"name":"Deparment of Endocrinology and Metabolic Diseases, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara 06800, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101733","DOI":"10.1016\/j.ando.2025.101733","article-title":"ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer","volume":"86","author":"Lasolle","year":"2025","journal-title":"Ann. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eprac.2024.01.001","article-title":"Survival Outcomes of Medullary Thyroid Cancer with and Without Amyloid Deposition","volume":"30","author":"Toraih","year":"2024","journal-title":"Endocr. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e230319","DOI":"10.1530\/ERC-23-0319","article-title":"Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000\u20132020: A population-based retrospective cohort study","volume":"31","author":"Tao","year":"2024","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s11845-021-02886-8","article-title":"Surgical aspects and controversies in the management of medullary thyroid cancer","volume":"191","author":"Green","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Matrone, A., Gambale, C., Prete, A., and Elisei, R. (2022). Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.864253"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kaliszewski, K., Ludwig, M., Ludwig, B., Miku\u0142a, A., Greniuk, M., and Rudnicki, J. (2022). Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?. Cancers, 14.","DOI":"10.3390\/cancers14153643"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-023-03326-6","article-title":"Diagnostic tests for medullary thyroid carcinoma: An umbrella review","volume":"81","author":"Trimboli","year":"2023","journal-title":"Endocrine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gambardella, C., Offi, C., Patrone, R., Clarizia, G., Mauriello, C., Tartaglia, E., Di Capua, F., Di Martino, S., Romano, R.M., and Fiore, L. (2019). Calcitonin negative Medullary Thyroid Carcinoma: A challenging diagnosis or a medical dilemma?. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0367-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12022-021-09664-3","article-title":"Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations","volume":"32","author":"Barletta","year":"2021","journal-title":"Endocr. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.21037\/gs-2019-catp-21","article-title":"Updates in the advances of sporadic medullary thyroid carcinoma: From the molecules to the clinic","volume":"9","author":"Bai","year":"2020","journal-title":"Gland Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ando.2019.04.014","article-title":"Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma","volume":"80","author":"Elisei","year":"2019","journal-title":"Ann. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijsu.2017.02.064","article-title":"Genetics of medullary thyroid cancer: An overview","volume":"41 (Suppl S1)","author":"Accardo","year":"2017","journal-title":"Int. J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","article-title":"Medullary thyroid carcinoma","volume":"22","author":"Pacini","year":"2010","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"705036","DOI":"10.1155\/2012\/705036","article-title":"Genetic and clinical features of multiple endocrine neoplasia types 1 and 2","volume":"2012","author":"Romei","year":"2012","journal-title":"J. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: An update","volume":"98","author":"Wells","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e3582","DOI":"10.1210\/clinem\/dgab326","article-title":"Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma","volume":"106","author":"Raue","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s12020-024-03959-1","article-title":"Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer","volume":"85","author":"Machens","year":"2024","journal-title":"Endocrine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109549","DOI":"10.1016\/j.ejso.2024.109549","article-title":"Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancer","volume":"51","author":"Machens","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jendso\/bvaa046.2101","article-title":"MON-LB015 Sporadic MTC in Children: Characterization of a Rare Disease","volume":"4","author":"Gammons","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.anl.2015.12.016","article-title":"Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience","volume":"43","author":"Kihara","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108625","DOI":"10.1016\/j.ejso.2024.108625","article-title":"Origin and impact of multifocal growth in sporadic vs. hereditary medullary thyroid cancer","volume":"50","author":"Machens","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/clinem\/dgae133","article-title":"Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades","volume":"109","author":"Hensley","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","unstructured":"Amin, M.B., Edge, S.B., Greene, F.L., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., and Sullivan, D.C. (2017). AJCC Cancer Staging Manual, Springer. [8th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1089\/thy.2020.0167","article-title":"Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades","volume":"31","author":"Kotwal","year":"2021","journal-title":"Thyroid"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda System for Reporting Thyroid Cytopathology: A meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1530\/EC-21-0030","article-title":"Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: A meta-analysis","volume":"10","author":"Vardarli","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Broecker-Preuss, M., Simon, D., Fries, M., Kornely, E., Weber, M., Vardarli, I., Gilman, E., Herrmann, K., and G\u00f6rges, R. (2023). Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules. Cancers, 15.","DOI":"10.3390\/cancers15082333"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s40618-020-01456-6","article-title":"Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma","volume":"44","author":"Moura","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_31","first-page":"CD010159","article-title":"Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules","volume":"3","author":"Verbeek","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/07435800.2024.2344103","article-title":"Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome","volume":"49","author":"Prinzi","year":"2024","journal-title":"Endocr. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000478-200110000-00004","article-title":"Sporadic versus familial medullary thyroid microcarcinoma: A histopathologic study of 50 consecutive patients","volume":"25","author":"Kaserer","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhang, D., Liang, N., Sun, H., Frattini, F., Sui, C., Yang, M., Wang, H., and Dionigi, G. (2024). Critically evaluated key points on hereditary medullary thyroid carcinoma. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1412942"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:59Z","timestamp":1760032799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071164"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071164","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}